Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the...
132 insider purchases on record · latest filing 2026-08-31.
Insiders have also filed 36 sale transactions at ALZN.